Lajolla Institute For Allergy And Immunology competitive analysis

Explore Lajolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Feb 5, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1

Latest PTAB cases involving Lajolla Institute For Allergy And Immunology

Discover the latest PTAB cases involving Lajolla Institute For Allergy And Immunology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lajolla Institute For Allergy And Immunology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 5, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LAJOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY - 1 - -
EUROPEAN OPPOSITIONS30 - - -